Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

Advancements in Cardiology Research & Reports

Research Article(ISSN: 2770-5447)

Comparative Stratification of Cardiovascular Risk through Framingham and Globo Risk in Patients with Psoriasis of IAHULA November 2017-May 2018. Volume 3 - Issue 1

José Sampayo1*, Luis Dulcey2, Camilo Cazorla3, Héctor Moreno4, Nohemi Molina5, Diana Villamizar6, Louis Soucre7 and Raimondo Caltagirone8

  • 1-4Internal Medicine Residents ULA Mérida, Venezuela
  • 5ULA Mérida Undergraduate Student, Venezuela
  • 6Specialist in Physiatry ULA Mérida, Venezuela
  • 7Specialist in Dermatology ULA Mérida, Venezuela
  • 8Specialist in Internal Medicine Critical Care ULA Mérida, Venezuela

Received: June 06, 2020;   Published: June 24, 2020

Corresponding author: Jose Jorge Sampayo, Internal Medicine Residents ULA Mérida, Venezuela

DOI: 10.32474/ACR.2020.03.000151


Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF


Objectives: To know the frequency of Metabolic Syndrome in patients with Psoriasis who come to the consultation of the Dermatology Service of the Autonomous University Hospital of the Andes November 2017 to May 2018.

Materials and Methods: Observational analytical descriptive study. Patients with Psoriasis diagnoses who attended the dermatology office were selected, PASI, ATP-III, Framingham and GLOBORISK were applied.

Results: 55 patients, 55% men and 45% women, there was statistical correlation between older age groups and PASI index (p=0.023). The main modifiable cardiovascular risk factors were smoking, sedentary lifestyle and obesity, statistical correlation was found for sedentary lifestyle (p=0.047). The main non-modifiable cardiovascular risk factors were Hypertension and Diabetes showing both statistical significance (p=0.004), (p=0.0001). The ATP-III criteria showed statistical significance for Hypertension, glycemia, total cholesterol and low HDL (p=0.003, p=0.008, p=0.027, p=0.017). The frequency of metabolic syndrome represented 47.27% of the sample. The most affected gender was male (61.54%). Statistical correlation was found in the older age groups for the presence of Metabolic Syndrome (p=0.0001). The group with the highest frequency of metabolic syndrome was the one with 6 to 10 years of the disease (p=0.001). When applying the Framingham and GLOBORISK scores, there were higher scores in the patients as PASI was increased.

Conclusion: There is a higher frequency of Metabolic Syndrome in patients with Psoriasis, so it is recommended to establish measures aimed at reducing the burden of cardiovascular disease in these patients.

Keywords: Psoriasis; Metabolic Syndrome; Risk; Severity Index of the Disease

Abstract| Introduction| Objectives | Results | Discussion| Recommendations| References|